MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40792-021-01253-0

Медицинская библиотека · Surgical case reports · 2021

Chemotherapy resumption in breast cancer patient after COVID-19.

Horiguchi Julian, Nakashoji Ayako, Kawahara Naoki, Matsui Akira, Kinoshita Takayuki

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

While many studies have verified the effect of recent anti-cancer treatment in patients with COVID-19, there are no data on the optimal time for cancer treatment resumption, as well as the safety of chemotherapy in COVID-19 patients. As many cancer patients are recovering from COVID-19, there is an urgent need for reliable clinical information. Herein, we report a case of invasive ductal carcinoma in which we were able to successfully resume chemotherapy after infection with SAR-CoV-2.

CASE PRESENTATION: The patient was a 38-year-old non-smoking Japanese woman with no significant medical history. She had fever on days 5 and 6 of her second course of adjuvant FEC therapy, and on day 7, she tested positive for SARS-CoV-2 by RT-PCR. She was hospitalized for 11 days. We resumed the therapy on day 25 after discharge, as she had no remaining clinical symptoms. The patient completed four courses of the initial chemotherapy without any major adverse events nor the recurrence of COVID-19, and subsequently completed four courses of docetaxel as her second regimen therapy.

CONCLUSIONS

Evaluating the risk for each patient is essential when resuming anti-cancer therapy in cancer patient's post-COVID-19.

Для цитирования: Horiguchi Julian, Nakashoji Ayako, Kawahara Naoki, Matsui Akira, Kinoshita Takayuki. Chemotherapy resumption in breast cancer patient after COVID-19.. Surgical case reports. 2021. DOI: 10.1186/s40792-021-01253-0.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.